Giovanna Mantovani Selected Research

Pseudohypoparathyroidism

1/2022	Lack of GNAS Remethylation During Oogenesis May Be a Cause of Sporadic Pseudohypoparathyroidism Type Ib.
2/2021	Inactivating PTH/PTHrP signaling disorders (iPPSDs): evaluation of the new classification in a multicenter large series of 544 molecularly characterized patients.
1/2021	Pseudohypoparathyroidism: Focus on Cerebral and Renal Calcifications.
1/2021	Pseudohypoparathyroidism, acrodysostosis, progressive osseous heteroplasia: different names for the same spectrum of diseases?
1/2020	Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and Patients.
1/2019	Hypercalcitoninaemia in pseudohypo-parathyroidism type 1A and type 1B.
1/2019	Inactivating PTH/PTHrP Signaling Disorders.
1/2019	2q37 Deletions in Patients With an Albright Hereditary Osteodystrophy Phenotype and PTH Resistance.
12/2018	Parathyroid hormone resistance syndromes - Inactivating PTH/PTHrP signaling disorders (iPPSDs).
1/2018	Genetic and Epigenetic Defects at the GNAS Locus Lead to Distinct Patterns of Skeletal Growth but Similar Early-Onset Obesity.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giovanna Mantovani Research Topics

Disease

32	Neoplasms (Cancer) 05/2022 - 12/2004
31	Pseudohypoparathyroidism 01/2022 - 09/2003
19	Pituitary Neoplasms (Pituitary Adenoma) 01/2022 - 10/2003
8	Hypocalcemia 01/2022 - 01/2013
6	Neuroendocrine Tumors (Neuroendocrine Tumor) 05/2022 - 07/2013
6	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2022 - 11/2005
6	Obesity 02/2021 - 12/2004
5	Hypothyroidism 01/2022 - 09/2007
5	Pituitary ACTH Hypersecretion 08/2021 - 09/2014
5	Acromegaly 07/2021 - 01/2010
5	Prolactinoma (Prolactinomas) 01/2019 - 01/2005
5	Adenoma (Adenomas) 01/2019 - 10/2002
4	COVID-19 05/2022 - 01/2020
4	Hyperphosphatemia 01/2022 - 01/2013
4	Acrodysostosis 01/2019 - 12/2012
4	Familial Hypoadrenocorticism 05/2006 - 01/2002
3	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2022 - 10/2012
3	Cushing Syndrome 01/2022 - 04/2017
3	Rare Diseases (Rare Disease) 02/2021 - 01/2013
3	Carcinoid Tumor (Carcinoid) 01/2021 - 07/2013
3	Progressive Osseous Heteroplasia 01/2019 - 05/2015
3	ACTH-Secreting Pituitary Adenoma 01/2019 - 09/2014
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2022
2	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2017
2	Hypopituitarism (Sheehan's Syndrome) 01/2022 - 10/2020
2	Carcinoma (Carcinomatosis) 01/2021 - 02/2016
2	Hyponatremia 01/2021 - 01/2013
2	Endocrine System Diseases (Endocrine Diseases) 01/2021 - 12/2006
2	Hemorrhage 10/2020 - 01/2013
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 01/2018
2	Brachydactyly 01/2020 - 05/2015
2	Imprinting Disorders 01/2018 - 04/2014
2	Azoospermia 02/2003 - 01/2002
1	Acute Kidney Injury (Acute Renal Failure) 05/2022
1	Pneumonia (Pneumonitis) 05/2022
1	Septic Shock (Toxic Shock Syndrome) 05/2022
1	Sepsis (Septicemia) 05/2022
1	Diabetes Insipidus 01/2022

Drug/Important Bio-Agent (IBA)

22	Hormones (Hormone)IBA 05/2022 - 09/2003
17	Parathyroid Hormone (Parathormone)IBA 01/2022 - 05/2006
15	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2008
13	Growth Hormone (Somatotropin)IBA 01/2022 - 12/2004
11	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 05/2022 - 11/2005
10	GTP-Binding Proteins (G-Protein)IBA 01/2021 - 10/2003
9	Adrenocorticotropic Hormone (ACTH)FDA Link 05/2022 - 10/2012
7	Dopamine Receptors (Dopamine Receptor)IBA 01/2022 - 09/2014
7	ProlactinIBA 01/2022 - 01/2010
7	FilaminsIBA 01/2021 - 03/2012
5	GonadotropinsIBA 03/2021 - 01/2002
5	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2019 - 05/2006
5	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 08/2016 - 12/2004
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2013
4	Hydrocortisone (Cortisol)FDA LinkGeneric 08/2021 - 03/2016
4	somatostatin receptor 2IBA 01/2021 - 04/2017
4	5-phenylpent-4-enyl-1-hydroperoxideIBA 01/2019 - 12/2004
3	pasireotideIBA 05/2022 - 01/2019
3	Parathyroid Hormone-Related ProteinIBA 01/2021 - 12/2016
3	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2020 - 06/2015
3	Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA 07/2013 - 09/2003
3	Orphan Nuclear ReceptorsIBA 05/2006 - 01/2002
2	Cabergoline FDA LinkGeneric 01/2022 - 01/2019
2	Everolimus FDA Link 01/2022 - 08/2020
2	somatostatin receptor 5IBA 01/2021 - 01/2019
2	Biological ProductsIBA 01/2021 - 01/2005
2	Thrombin FDA Link 01/2021 - 05/2017
2	Denosumab FDA Link 01/2021 - 09/2016
2	Testosterone (Sustanon)FDA Link 12/2020 - 01/2019
2	2-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA 10/2020 - 01/2014
2	Dopamine Agents (Dopaminergic Agents)IBA 01/2020 - 01/2010
2	Calcitriol (Calcijex)FDA LinkGeneric 01/2020 - 01/2019
2	Octreotide (Sandostatin)FDA LinkGeneric 01/2020 - 11/2005
2	LigandsIBA 01/2020 - 04/2014
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2020
2	CalciumIBA 01/2019 - 01/2018
2	Caspase 3 (Caspase-3)IBA 01/2019 - 11/2005
2	Alkaline PhosphataseIBA 09/2016 - 01/2013
2	Dopamine (Intropin)FDA LinkGeneric 01/2015 - 02/2010
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 09/2014 - 04/2008
2	Carrier Proteins (Binding Protein)IBA 04/2014 - 03/2014
2	Guanine NucleotidesIBA 04/2014 - 03/2014
2	Peptides (Polypeptides)IBA 04/2014 - 03/2014
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2012 - 12/2006
2	Cyclic AMP (AMP, Cyclic)IBA 02/2011 - 03/2009
2	Protein Isoforms (Isoforms)IBA 03/2009 - 04/2008
2	Messenger RNA (mRNA)IBA 03/2009 - 12/2004
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2007 - 10/2003
2	RNA (Ribonucleic Acid)IBA 11/2005 - 10/2002
1	Ubiquitin-Specific ProteasesIBA 05/2022
1	proadrenomedullinIBA 05/2022
1	Capsules (Microcapsules)IBA 01/2022
1	Cyclin D3IBA 01/2022
1	Viral AntigensIBA 01/2022
1	ArrestinIBA 01/2022
1	TOR Serine-Threonine KinasesIBA 01/2022
1	beta-Arrestin 1IBA 01/2022
1	trans-crotonin (CTN)IBA 01/2022

Therapy/Procedure

19	Therapeutics 01/2022 - 11/2010
3	Radiotherapy 01/2021 - 01/2010
2	Length of Stay 05/2022 - 01/2021
1	Adrenalectomy 01/2022